This promotional webinar has been funded and developed by Novartis UK Ltd and is intended for UK healthcare professionals only.

Three key takeaways

  • Emphasise the urgency to lower LDL-C to target, defining the secondary prevention LDL-C targets and national guidelines.
  • Real-world experiences of implementing lipid lowering therapies within general practice including practical tips for identifying and initiating patients eligible for escalated lipid lowering therapy.
  • Share learnings and discuss importance of the role of pharmacy teams in implementing lipid lowering therapies in primary care.

Chair:

Nipa Patel, PCPA Regional Vice President - London and SE| Lead Pharmacist SASSE 2 & 3

Speakers:

Prof Raj Thakkar, PCCS President and CKD representative GP Partner

Sarah Trust, MPharm Clinical Pharmacist, Brighton & Sussex PCN